F-star Biotechnology Revenue and Competitors
Estimated Revenue & Valuation
- F-star Biotechnology's estimated annual revenue is currently $7.6M per year.
- F-star Biotechnology's estimated revenue per employee is $155,000
Employee Data
- F-star Biotechnology has 49 Employees.
- F-star Biotechnology grew their employee count by -32% last year.
F-star Biotechnology's People
| Name | Title | Email/Phone |
|---|---|---|
1 | COO | Reveal Email/Phone |
2 | CFO | Reveal Email/Phone |
3 | Chief Medical Officer | Reveal Email/Phone |
4 | Chief Financial Officer | Reveal Email/Phone |
5 | VP, Business Development & Corporate Strategy | Reveal Email/Phone |
6 | VP, Finance and corporate controller | Reveal Email/Phone |
7 | Head Bioanalytical Science | Reveal Email/Phone |
8 | Head Business Operations and EA to the Head F-star | Reveal Email/Phone |
9 | Associate Director Finance | Reveal Email/Phone |
10 | Chief Development Officer at F-star Therapeutics | Reveal Email/Phone |
F-star Biotechnology Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.4M | 35 | -12% | N/A | N/A |
#2 | $16.3M | 105 | 4% | N/A | N/A |
#3 | $107.2M | 494 | 25% | $292M | N/A |
#4 | $2.6M | 830 | 30% | $631.7M | N/A |
#5 | $18.1M | 117 | -8% | $81M | N/A |
#6 | $1.2M | 271 | 12% | $440M | N/A |
#7 | $54.6M | 282 | 0% | $132.9M | N/A |
#8 | $9.3M | 60 | -37% | N/A | N/A |
#9 | $21.2M | 137 | 12% | N/A | N/A |
#10 | $408.2M | 1646 | 11% | £994.6M | N/A |
What Is F-star Biotechnology?
F-star is a clinical-stage biopharmaceutical company committed to delivering life-changing treatments to cancer patients. Through our highly efficient Modular Antibody Technology platform, we are building and progressing an extensive immuno-oncology pipeline of mAb², a novel class of disruptive bispecific antibodies designed to unlock new biology which cannot be achieved by combining monospecific drugs. F-star's technological expertise and scientific approach have been validated through strategic partnerships with leaders in the pharma and biotech industries. Find out more at www.f-star.com.
keywords:Biotechnology,Healthcare,Pharmaceuticals
N/A
Total Funding
49
Number of Employees
$7.6M
Revenue (est)
-32%
Employee Growth %
N/A
Valuation
N/A
Accelerator
F-star Biotechnology News
... F-star Gamma Limited, F-star Biotechnologische Forschungs-Und Entwicklungsges M.B.H, F-star Biotechnology Limited, SIRION Biotech GmbH,...
... and biotechnology industries across all phases of drug development. Before joining F-star Therapeutics James served as Chief Development...
CAMBRIDGE, England and CAMBRIDGE, Mass., Dec. 3, 2020 /PRNewswire/ -- F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical company dedicated to developing next generation immunotherapies to transform the lives of patients with cancer, today announces that the first pati ...
CAMBRIDGE, England and CAMBRIDGE, Mass., Oct. 22, 2020 /PRNewswire/ -- F-star Therapeutics Ltd., a clinical-stage immuno-oncology company focused on transforming the lives of patients with cancer through the development of innovative tetravalent bispecific (mAb2™) antibodies, today announced t ...
F-star expands its relationship with Merck through a new strategic collaboration 05-06-2017 F-star, a biopharmaceutical company developing novel bispecific antibodies, announces today a new partnership with Merck, a leading science and technology company, for the development and commercialisat ...
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $3.8M | 49 | -20% | $22.5M |
#2 | $5.7M | 49 | 29% | N/A |
#3 | $3.5M | 49 | 23% | $26.1M |
#4 | $7.6M | 49 | 11% | N/A |
#5 | $3.5M | 49 | 4% | N/A |